BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

758 related articles for article (PubMed ID: 15022282)

  • 21. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
    Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
    Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study on the value of Inhibin B in the diagnosis of nasopharyngeal carcinoma and its correlation with traditional Chinese medicine syndromes: An observational study.
    Ma N; Deng X; Liu Q; Xu F; Guo Q; Yan K; Yang Y; Zou G
    Medicine (Baltimore); 2024 Jun; 103(23):e38416. PubMed ID: 38847724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum anti-EBV IgA is inversely related to tumor infiltration by surface IgA positive lymphocytes in nasopharyngeal carcinoma.
    Gunvén P; Klein G; Henle W; Henle G; Forsby N
    Biomed Pharmacother; 1983; 37(1):41-4. PubMed ID: 6311307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Significance of virus-specific antibodies to EBV-antigens in patients with nasopharyngeal carcinoma (author's transl)].
    Wilmes E; Wolf H; Deinhardt F; Naumann HH
    Laryngol Rhinol Otol (Stuttg); 1979 Dec; 58(12):911-5. PubMed ID: 231716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Epstein-Barr virus (Herpesviridae:
    Smirnova KV; Lubenskaya AK; Senyuta NB; Dushenkina TE; Gurtsevitch VE
    Vopr Virusol; 2023 Sep; 68(4):291-301. PubMed ID: 38156586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IgA/VCA as a follow-up marker in the monitoring of nasopharyngeal carcinoma.
    Sam CK; Abu-Samah AJ; Prasad U
    Eur J Surg Oncol; 1994 Oct; 20(5):561-4. PubMed ID: 7926060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [EBV-specific antibodies in patients with nasopharyngeal cancer and tonsillar cancer. Follow-up of over 4 years].
    Oberender H; Nowak R; Donner A; Brichacek E; Vonka V; Teterin W; Kunkel M
    Laryngorhinootologie; 1989 Mar; 68(3):181-5. PubMed ID: 2540762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two-step Epstein-Barr virus immunoglobulin A enzyme-linked immunosorbent assay system for serological screening and confirmation of nasopharyngeal carcinoma.
    Paramita DK; Fachiroh J; Haryana SM; Middeldorp JM
    Clin Vaccine Immunol; 2009 May; 16(5):706-11. PubMed ID: 19321695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma.
    Henle G; Henle W
    Int J Cancer; 1976 Jan; 17(1):1-7. PubMed ID: 175020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Titers of Epstein-Barr virus-related antibodies in nasopharyngeal carcinoma in Japan.
    Tamada A; Makimoto K; Yamabe H; Imai J; Hinuma Y; Oyagi A; Araki T
    Cancer; 1984 Feb; 53(3):430-40. PubMed ID: 6318948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered humoral immunity against cytomegalovirus and Epstein-Barr virus without detectable virus antigens and virus-DNA in the glomeruli of patients with IGA nephropathy in remission phase.
    Nagy J; Haikin H; Sarov B; Háber A; Kun L; Sarov I
    Acta Microbiol Immunol Hung; 1995; 42(2):179-87. PubMed ID: 7551711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The interaction and mediation effects between the host genetic factors and Epstein-Barr virus VCA-IgA in the risk of nasopharyngeal carcinoma.
    Diao H; Xue WQ; Wang TM; Yang DW; Deng CM; Li DH; Zhang WL; Liao Y; Wu YX; Chen XY; Zhou T; Li XZ; Zhang PF; Zheng XH; Zhang SD; Hu YZ; Cao SM; Liu Q; Ye WM; He YQ; Jia WH
    J Med Virol; 2023 Nov; 95(11):e29224. PubMed ID: 37970759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic value of measuring Epstein-Barr virus (EBV) DNA load and carcinoma-specific viral mRNA in relation to anti-EBV immunoglobulin A (IgA) and IgG antibody levels in blood of nasopharyngeal carcinoma patients from Indonesia.
    Stevens SJ; Verkuijlen SA; Hariwiyanto B; Harijadi ; Fachiroh J; Paramita DK; Tan IB; Haryana SM; Middeldorp JM
    J Clin Microbiol; 2005 Jul; 43(7):3066-73. PubMed ID: 16002393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
    Joncas JH; Wills A; Reece E; Fox Z
    Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enzyme-linked immunosorbent assay for antibodies to Epstein-Barr virus-associated early antigens and the viral capsid antigen.
    Dölken G; Boldt C; Lange W; Weitzmann U; Löhr GW; Rosén A
    Cancer Detect Prev; 1983; 6(1-2):287-92. PubMed ID: 6309387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histological types of nasopharyngeal carcinoma as compared to EBV serology.
    Krueger GR; Kottaridis SD; Wolf H; Ablashi DV; Sesterhenn K; Bertram G
    Anticancer Res; 1981; 1(4):187-94. PubMed ID: 6285799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Chinese epidemiological approach of nasopharyngeal carcinoma research and control.
    De-Thé G
    Yale J Biol Med; 1981; 54(1):33-9. PubMed ID: 6264696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression of the Epstein-Barr virus P150 viral capsid antigen in Escherichia coli for the use as antigen in diagnostic tests].
    Fan JA
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Oct; 11(5):381-7. PubMed ID: 2561513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The clinical usefulness of the serological study of IgG antibodies and IgA against the antigens associated with the Epstein-Barr virus in patients with nasopharyngeal carcinoma].
    Amador García JM; Mendoza Montero J; Expósito Hernández J; Salinero Hernández J; Esquivias López-Cuerpo J; Ballesteros García P
    Acta Otorrinolaringol Esp; 1992; 43(1):31-6. PubMed ID: 1316136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequent association of Epstein-Barr virus in Japanese patients with Burkitt's lymphoma.
    Okano M; Kikuta H; Abo W; Koizumi S; Aya T; Yano S; Takada K; Mizuno F; Osato T
    Jpn J Clin Oncol; 1992 Oct; 22(5):320-4. PubMed ID: 1281896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.